Literature DB >> 15808160

Multiple laser treatments for macular edema attributable to branch retinal vein occlusion.

Erica Esrick1, Manju L Subramanian, Jeffrey S Heier, Anand K Devaiah, Trexler M Topping, Albert R Frederick, Michael G Morley.   

Abstract

PURPOSE: To report the visual outcome of multiple laser treatments for macular edema attributable to branch retinal vein occlusions (BRVO) and to determine if any prognostic factors exist for improvement.
DESIGN: Retrospective chart review.
METHODS: A private practice with four vitreoretinal surgeons performed laser treatments on 88 eyes of 88 patients with macular edema secondary to BRVO from 1984 to 2003. Mean preoperative and postoperative visual acuities were collected after each laser treatment. Final visual acuities were also documented.
RESULTS: All 88 patients received at least one laser treatment, and 46 patients of the initial 88 underwent multiple treatments. Overall, forty-one (46.6%) of the total 88 patients improved by 2 or more lines, whereas 33 patients (37.5%) were within 1 line of the preoperative vision, and 14 patients (15.9%) worsened by 2 or more lines. The mean final visual improvement was 0.92 lines for all 88 patients. The group of patients that responded favorably to the first laser treatment (n = 37) showed an overall improvement of 3.5 lines. However, patients who responded poorly to the first laser treatment resulted in an overall worsening of vision by 0.96 lines.
CONCLUSIONS: Our study found that multiple laser treatments can improve visual acuity and resolve macular edema and that each additional laser treatment gives a patient a modest chance of visual improvement. A positive or stable visual response to first laser treatment portends a favorable prognosis with subsequent laser treatments.

Entities:  

Mesh:

Year:  2005        PMID: 15808160     DOI: 10.1016/j.ajo.2004.11.011

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Tomoaki Murakami; Mihori Kita; Kazuaki Miyamoto; Atsushi Sakamoto; Noritatsu Yamaike; Nagahisa Yoshimura
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

2.  Lamellar macular hole formation in chronic cystoid macular edema associated with retinal vein occlusion.

Authors:  Kayoko Tsukada; Akitaka Tsujikawa; Tomoaki Murakami; Ken Ogino; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2011-07-09       Impact factor: 2.447

3.  Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion.

Authors:  Bin Mo; Hai-Ying Zhou; Xuan Jiao; Feng Zhang
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

4.  Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).

Authors:  Siamak Moradian; Hooshang Faghihi; Babak Sadeghi; Niloofar Piri; Hamid Ahmadieh; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina; Mohammad Riazi Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

5.  Retinal sensitivity after resolution of the macular edema associated with retinal vein occlusion.

Authors:  Masafumi Ota; Akitaka Tsujikawa; Yumiko Ojima; Kazuaki Miyamoto; Tomoaki Murakami; Ken Ogino; Yumiko Akagi-Kurashige; Yuki Muraoka; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-18       Impact factor: 3.117

6.  Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.

Authors:  Thomas Ach; Alexandra E Hoeh; Karen B Schaal; Alexander F Scheuerle; Stefan Dithmar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-09       Impact factor: 3.117

7.  Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.

Authors:  Jin Young Kim; Sung Pyo Park
Journal:  Korean J Ophthalmol       Date:  2009-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.